RFPL4B

gene
On this page

Also known as RNF211

Summary

RFPL4B (ret finger protein like 4B, HGNC:33264) is a protein-coding gene on chromosome 6q21, encoding Ret finger protein-like 4B (Q6ZWI9).

Predicted to enable ubiquitin protein ligase activity. Predicted to be involved in innate immune response and regulation of gene expression. Predicted to be active in cytoplasm.

Source: NCBI Gene 442247 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 42 total
  • MANE Select transcript: NM_001013734

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:33264
Approved symbolRFPL4B
Nameret finger protein like 4B
Location6q21
Locus typegene with protein product
StatusApproved
AliasesRNF211
Ensembl geneENSG00000251258
Ensembl biotypeprotein_coding
Entrez442247

Gene structure

Transcript identifiers

Ensembl transcripts: 2 — 2 protein_coding

ENST00000441065, ENST00000962225

RefSeq mRNA: 1 — MANE Select: NM_001013734 NM_001013734

CCDS: CCDS34515

Canonical transcript exons

ENST00000441065 — 3 exons

ExonStartEnd
ENSE00002289141112347330112347407
ENSE00002304888112349604112351294
ENSE00003577974112349193112349321

Expression profiles

Bgee: expression breadth broad, 21 present calls, max score 88.99.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2470 / max 127.1286, expressed in 68 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
693280.247068

Top tissues by expression

122 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099188.99gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047386.80gold quality
placentaUBERON:000198754.97gold quality
testisUBERON:000047353.96gold quality
right testisUBERON:000453453.11gold quality
left testisUBERON:000453352.40gold quality
colonic epitheliumUBERON:000039741.39gold quality
ventricular zoneUBERON:000305340.14gold quality
ganglionic eminenceUBERON:000402337.56silver quality
cortical plateUBERON:000534336.47gold quality
smooth muscle tissueUBERON:000113536.46silver quality
bone marrow cellCL:000209236.16gold quality
cortex of kidneyUBERON:000122535.69silver quality
metanephros cortexUBERON:001053335.01gold quality
kidneyUBERON:000211334.87gold quality
gall bladderUBERON:000211034.85silver quality
adult mammalian kidneyUBERON:000008233.63gold quality
skeletal muscle tissueUBERON:000113433.38gold quality
calcaneal tendonUBERON:000370132.89gold quality
vermiform appendixUBERON:000115432.68silver quality
hindlimb stylopod muscleUBERON:000425232.15gold quality
bone marrowUBERON:000237131.74gold quality
prefrontal cortexUBERON:000045131.01gold quality
sural nerveUBERON:001548830.93gold quality
islet of LangerhansUBERON:000000629.88gold quality
superior frontal gyrusUBERON:000266129.88gold quality
stromal cell of endometriumCL:000225529.87gold quality
liverUBERON:000210729.83gold quality
thoracic aortaUBERON:000151529.41silver quality
endometriumUBERON:000129529.26gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no1.97

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

38 targeting RFPL4B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-5193100.0067.261744
HSA-MIR-4668-3P100.0068.742635
HSA-MIR-3646100.0073.565283
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-3692-3P99.9870.272139
HSA-MIR-3065-5P99.9771.563281
HSA-MIR-570-3P99.9672.414910
HSA-MIR-101-3P99.9475.032230
HSA-MIR-1236-3P99.9468.041695
HSA-MIR-6809-3P99.9171.453814
HSA-MIR-548AR-3P99.8571.263889
HSA-MIR-548AZ-3P99.8270.563549
HSA-MIR-548BC99.8270.613524
HSA-MIR-548E-3P99.8270.593514
HSA-MIR-548F-3P99.8270.593540
HSA-MIR-6817-3P99.7968.352126
HSA-MIR-548A-3P99.7670.583524
HSA-MIR-187-5P99.7470.261404
HSA-MIR-4699-3P99.7170.153142
HSA-MIR-128399.6972.423009
HSA-MIR-58699.6570.402051
HSA-MIR-4687-3P99.4866.41968
HSA-MIR-6507-5P99.3670.462524
HSA-MIR-19A-5P99.3666.931675
HSA-MIR-19B-1-5P99.3667.071669
HSA-MIR-19B-2-5P99.3667.071669
HSA-MIR-797499.2465.481137
HSA-MIR-5584-3P99.2368.791351
HSA-MIR-146A-3P99.1368.991881
HSA-MIR-3152-3P99.1066.35678

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusRfpl4bENSMUSG00000094311
rattus_norvegicusAABR07045341.1ENSRNOG00000058648

Paralogs (12): CD86 (ENSG00000114013), CD274 (ENSG00000120217), CD80 (ENSG00000121594), RFPL1 (ENSG00000128250), RFPL2 (ENSG00000128253), RFPL3 (ENSG00000128276), SPRYD4 (ENSG00000176422), RNF152 (ENSG00000176641), RNF135 (ENSG00000181481), PDCD1LG2 (ENSG00000197646), RFPL4A (ENSG00000223638), RFPL4AL1 (ENSG00000229292)

Protein

Protein identifiers

Ret finger protein-like 4BQ6ZWI9 (reviewed: Q6ZWI9)

Alternative names: RING finger protein 211

All UniProt accessions (1): Q6ZWI9

RefSeq proteins (1): NP_001013756* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001841Znf_RINGDomain
IPR001870B30.2/SPRYDomain
IPR003877SPRY_domDomain
IPR003879Butyrophylin_SPRYDomain
IPR006574PRYDomain
IPR013083Znf_RING/FYVE/PHDHomologous_superfamily
IPR013320ConA-like_dom_sfHomologous_superfamily
IPR017907Znf_RING_CSConserved_site
IPR043136B30.2/SPRY_sfHomologous_superfamily
IPR050143TRIM/RBCCFamily

Pfam: PF00622, PF13765, PF15227

UniProt features (5 total): chain 1, domain 1, zinc finger region 1, sequence variant 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q6ZWI9-F183.420.42

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 24 (showing top): GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, GOMF_ACYLTRANSFERASE_ACTIVITY, GOMF_AMINOACYLTRANSFERASE_ACTIVITY, GOMF_UBIQUITIN_LIKE_PROTEIN_LIGASE_ACTIVITY, GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_UP, MIR570_3P, MIR1283, MIR101_3P, MIR4699_3P, MIR6817_3P, MIR146A_3P, MIR6830_3P, MIR5193, MIR6818_3P, MIR3152_3P

GO Biological Process (2): regulation of gene expression (GO:0010468), innate immune response (GO:0045087)

GO Molecular Function (4): zinc ion binding (GO:0008270), ubiquitin protein ligase activity (GO:0061630), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (1): cytoplasm (GO:0005737)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
gene expression1
regulation of macromolecule biosynthetic process1
immune response1
defense response to symbiont1
transition metal ion binding1
ubiquitin-protein transferase activity1
ubiquitin-like protein ligase activity1
binding1
cation binding1
intracellular anatomical structure1
cellular anatomical structure1

Protein interactions and networks

STRING

378 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
RFPL4BKHDC1LQ5JSQ8544
RFPL4BPRAMEF25A6NGN4520
RFPL4BA0A096LNW4A0A096LNW4506
RFPL4BKHDC1Q4VXA5479
RFPL4BPRAMEF15P0DUQ1479
RFPL4BZSCAN4Q8NAM6473
RFPL4BCLPSL1A2RUU4449
RFPL4BPRAMEF1O95521448
RFPL4BMBD3L2Q8NHZ7447
RFPL4BMBD3L3A6NE82446
RFPL4BGOLGA6BA6NDN3439
RFPL4BMBD3L5A6NJ08415
RFPL4BDUX4L2P0CJ85400
RFPL4BPRAMEF2O60811397
RFPL4BCT45A10P0DMU9392

IntAct

7 interactions, top by confidence:

ABTypeScore
RFPL4BRFPL4Apsi-mi:“MI:0914”(association)0.640
FAM90A1RFPL4Apsi-mi:“MI:0914”(association)0.530
RFPL4BKRBA1psi-mi:“MI:0914”(association)0.350
RFPL4BPOTEFpsi-mi:“MI:0914”(association)0.350

BioGRID (107): YEATS2 (Affinity Capture-MS), SALL2 (Affinity Capture-MS), SALL1 (Affinity Capture-MS), ZKSCAN1 (Affinity Capture-MS), ZNF324 (Affinity Capture-MS), ZZZ3 (Affinity Capture-MS), ZNF784 (Affinity Capture-MS), TAB1 (Affinity Capture-MS), CSRP2BP (Affinity Capture-MS), MIOS (Affinity Capture-MS), ZMYM6 (Affinity Capture-MS), RFPL4A (Affinity Capture-MS), POLR2J (Affinity Capture-MS), PER1 (Affinity Capture-MS), LRIF1 (Affinity Capture-MS)

ESM2 similar proteins: A6NK02, A6NLU0, D4ABM4, F8RKW2, F8VTS6, O75677, O75678, O75679, P15533, P62603, Q2T9Z0, Q3UWZ0, Q495X7, Q5BK82, Q5E9G4, Q5RBG2, Q5RKG6, Q5SZ99, Q62191, Q640S6, Q6AZZ1, Q6PGR9, Q6UX41, Q6UXE8, Q6ZWI9, Q7TPM3, Q7YR32, Q80X56, Q810I1, Q810I2, Q865W2, Q86WT6, Q86XT4, Q8BVP1, Q8C006, Q8K243, Q8N7C3, Q8N9V2, Q8R0K2, Q8VH31

Diamond homologs: A0A3B3IT33, A6NCK2, A6NDI0, A6NGJ6, A6NI03, A6NLI5, B0BLU1, C9J1S8, I1YAP6, O00478, O00481, O15344, O75677, O75678, O75679, O76064, P0CI25, P0CI26, P18892, P19474, P62603, P86448, P86449, Q13410, Q2HJ46, Q3C1V9, Q3TL54, Q4KLN8, Q5EBN2, Q5PQN2, Q5R4I2, Q5R996, Q61510, Q62556, Q6INS5, Q6MFY8, Q6UX41, Q6UXE8, Q6ZWI9, Q7T308

SIGNOR signaling

1 interactions.

AEffectBMechanism
Ub:E2“up-regulates activity”RFPL4Bubiquitination

Disease & clinical

Clinical variants and AI predictions

ClinVar

42 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance40
Likely benign2
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

308 predictions. Top by Δscore:

VariantEffectΔscore
6:112347404:CAAGG:Cdonor_loss1.0000
6:112347406:AG:Adonor_gain1.0000
6:112347407:GG:Gdonor_gain1.0000
6:112347407:GGT:Gdonor_loss1.0000
6:112347408:G:GAdonor_loss1.0000
6:112347408:G:GGdonor_gain1.0000
6:112349183:T:Aacceptor_gain1.0000
6:112349191:A:AGacceptor_gain1.0000
6:112349191:AGAG:Aacceptor_gain1.0000
6:112349192:G:GGacceptor_gain1.0000
6:112349192:GA:Gacceptor_gain1.0000
6:112349192:GAGG:Gacceptor_gain1.0000
6:112349318:CTAGG:Cdonor_loss1.0000
6:112349321:GGT:Gdonor_loss1.0000
6:112349322:G:GCdonor_loss1.0000
6:112349323:T:Adonor_loss1.0000
6:112347403:TCAAG:Tdonor_gain0.9900
6:112347405:AAGGT:Adonor_loss0.9900
6:112349186:A:AGacceptor_gain0.9900
6:112349187:C:Gacceptor_gain0.9900
6:112349188:T:Aacceptor_gain0.9900
6:112349189:GCAG:Gacceptor_loss0.9900
6:112349190:CA:Cacceptor_loss0.9900
6:112349191:A:Cacceptor_loss0.9900
6:112349192:G:GAacceptor_loss0.9900
6:112349192:GAGGA:Gacceptor_gain0.9900
6:112349306:G:GTdonor_gain0.9900
6:112349322:G:GGdonor_gain0.9900
6:112349590:A:AGacceptor_gain0.9900
6:112349601:TAG:Tacceptor_loss0.9900

AlphaMissense

1748 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
6:112350366:T:CF220L0.957
6:112350368:T:AF220L0.957
6:112350368:T:GF220L0.957
6:112350246:T:CF180L0.917
6:112350248:C:AF180L0.917
6:112350248:C:GF180L0.917
6:112349796:T:CF30L0.912
6:112349798:C:AF30L0.912
6:112349798:C:GF30L0.912
6:112350152:G:CW148C0.905
6:112350152:G:TW148C0.905
6:112350129:T:CF141L0.899
6:112350131:C:AF141L0.899
6:112350131:C:GF141L0.899
6:112350369:T:CF221L0.890
6:112350371:T:AF221L0.890
6:112350371:T:GF221L0.890
6:112350150:T:AW148R0.889
6:112350150:T:CW148R0.889
6:112350438:T:CF244L0.885
6:112350440:C:AF244L0.885
6:112350440:C:GF244L0.885
6:112350180:T:AW158R0.884
6:112350180:T:CW158R0.884
6:112350336:T:CF210L0.884
6:112350338:C:AF210L0.884
6:112350338:C:GF210L0.884
6:112350334:T:CI209T0.862
6:112350367:T:CF220S0.842
6:112350253:T:CI182T0.814

dbSNP variants (sampled 300 via entrez): RS1000052819 (6:112349101 C>G), RS1001982859 (6:112351415 A>G), RS1002551619 (6:112346438 A>C), RS1002581104 (6:112347184 T>C), RS1002612069 (6:112347345 C>A,G,T), RS1003564796 (6:112347512 A>T), RS1004919165 (6:112348494 C>T), RS1004952002 (6:112348829 T>G), RS1005786440 (6:112345699 T>C), RS1006171182 (6:112345532 T>G), RS1007739254 (6:112347292 G>A), RS1009140480 (6:112348393 T>C), RS1009166941 (6:112348700 C>A,G,T), RS1009519942 (6:112348054 A>T), RS1010190175 (6:112350726 T>C)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST005170_52Intraocular pressure1.000000e-08
GCST011517_3joint destruction in rheumatoid arthritis (rapid vs slow)1.000000e-06
GCST90000654_40Central corneal thickness3.000000e-08

EFO canonical traits (3, from GWAS)

EFO IDTrait name
EFO:0004695intraocular pressure measurement
EFO:0005413joint damage measurement
EFO:0005213central corneal thickness

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

PharmGKB clinical annotations

1 annotations.

VariantTypeLevelDrugsPhenotypes
rs9384825Metabolism/PK3o-desmethyltramadol;tramadol

PharmGKB variants

1 variants.

VariantGenesLevelScore#Clin annotsDrugs
rs9384825RFPL4B31.501o-desmethyltramadol;tramadol

CTD chemical–gene interactions

5 total (human), top 5 by PubMed support.

ChemicalActions (top 5)PubMed papers
abrineincreases expression1
Resveratrolaffects cotreatment, decreases expression1
Benzo(a)pyreneaffects methylation, increases methylation1
Plant Extractsaffects cotreatment, decreases expression1
1-Methyl-4-phenylpyridiniumincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.